Abbott Diagnostics:企業の製品パイプライン分析2018

◆英語タイトル:Abbott Diagnostics - Product Pipeline Analysis, 2018 Update
◆商品コード:DATA904C12776
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:396
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD1,500 ⇒換算¥163,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥245,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Abbott Diagnostics, a subsidiary of Abbott Laboratories, is a manufacturer of in vitro diagnostic systems and tests. The company offers core laboratory products, molecular point of care products, transfusion medicine, professional services and diagnostics portfolio. Its products include laboratory systems for automation; molecular diagnostic systems; and point of care systems for blood analysis. Its products find application in therapeutic drug monitoring, measurement of antibodies and antigens, and screening and diagnosis of cancer. It serves blood banks, hospitals, commercial laboratories, government agencies, patient care testing sites, and plasma protein therapeutic companies. The company markets its products through Abbott-owned distribution centers, public warehouses and third-party distributors. Abbott Diagnostics is headquartered in Lake Forest, Illinois, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Abbott Diagnostics
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 15
List of Figures 26
Abbott Diagnostics Company Overview 28
Abbott Diagnostics Company Snapshot 28
Abbott Diagnostics Pipeline Products and Ongoing Clinical Trials Overview 28
Abbott Diagnostics – Pipeline Analysis Overview 32
Abbott Diagnostics – Key Facts 32
Abbott Diagnostics – Major Products and Services 33
Abbott Diagnostics Pipeline Products by Development Stage 41
Abbott Diagnostics Ongoing Clinical Trials by Trial Status 57
Abbott Diagnostics Pipeline Products Overview 59
13q14.3 Companion Diagnostic Assay – Chronic Lymphocytic Leukemia 59
13q14.3 Companion Diagnostic Assay – Chronic Lymphocytic Leukemia Product Overview 59
ACTN4 Companion Diagnostic Assay – Lung Cancer 60
ACTN4 Companion Diagnostic Assay – Lung Cancer Product Overview 60
AKT Companion Diagnostic Assay – Breast Cancer 61
AKT Companion Diagnostic Assay – Breast Cancer Product Overview 61
AKT Companion Diagnostic Assay – Colorectal Cancer 62
AKT Companion Diagnostic Assay – Colorectal Cancer Product Overview 62
AKT Companion Diagnostic Assay – Renal Cancer 63
AKT Companion Diagnostic Assay – Renal Cancer Product Overview 63
Alere i Strep A 2 64
Alere i Strep A 2 Product Overview 64
Alinity c System 65
Alinity c System Product Overview 65
Alinity ci – Calcium 66
Alinity ci – Calcium Product Overview 66
Alinity ci – Cancer 67
Alinity ci – Cancer Product Overview 67
Alinity ci – Cardiac Diseases 68
Alinity ci – Cardiac Diseases Product Overview 68
Alinity ci – Glucose 69
Alinity ci – Glucose Product Overview 69
Alinity ci – Hormone Deficiency 70
Alinity ci – Hormone Deficiency Product Overview 70
Alinity ci – Infectious Diseases 71
Alinity ci – Infectious Diseases Product Overview 71
Alinity ci – Potassium 72
Alinity ci – Potassium Product Overview 72
Alinity ci – Sodium 73
Alinity ci – Sodium Product Overview 73
Alinity ci – TDM 74
Alinity ci – TDM Product Overview 74
Alinity ci – Thyroid Disease 75
Alinity ci – Thyroid Disease Product Overview 75
Alinity i System 76
Alinity i System Product Overview 76
Alinity PRO 77
Alinity PRO Product Overview 77
Alinity s System 78
Alinity s System Product Overview 78
ALK Companion Diagnostic Assay – Colorectal Cancer 79
ALK Companion Diagnostic Assay – Colorectal Cancer Product Overview 79
ALK Companion Diagnostic Assay – Lung Cancer 80
ALK Companion Diagnostic Assay – Lung Cancer Product Overview 80
AR Companion Diagnostic Assay – Breast Cancer 81
AR Companion Diagnostic Assay – Breast Cancer Product Overview 81
AR Companion Diagnostic Assay – Prostate Cancer 82
AR Companion Diagnostic Assay – Prostate Cancer Product Overview 82
ARCHITECT c16000 Integrated System – Galectin-3 Assay 83
ARCHITECT c16000 Integrated System – Galectin-3 Assay Product Overview 83
ARCHITECT c16000 System – Ca 72.2 Assay 84
ARCHITECT c16000 System – Ca 72.2 Assay Product Overview 84
ARCHITECT c16000 System – HbSAg Assay 85
ARCHITECT c16000 System – HbSAg Assay Product Overview 85
ARCHITECT c16000 System – High Sensitive Troponin – I Assay 86
ARCHITECT c16000 System – High Sensitive Troponin – I Assay Product Overview 86
ARCHITECT c16000 System – High Sensitive Troponin – I Assay Clinical Trial 87
ARCHITECT c16000 System – Methotrexate Assay 88
ARCHITECT c16000 System – Methotrexate Assay Product Overview 88
ARCHITECT c16000 System – NSE Assay 89
ARCHITECT c16000 System – NSE Assay Product Overview 89
ARCHITECT c16000 System – PCT Assay 90
ARCHITECT c16000 System – PCT Assay Product Overview 90
ARCHITECT c16000 System – PIVKA Assay 91
ARCHITECT c16000 System – PIVKA Assay Product Overview 91
ARCHITECT c16000 System – Tg Assay 92
ARCHITECT c16000 System – Tg Assay Product Overview 92
ARCHITECT c4000 – Galectin-3 Assay 93
ARCHITECT c4000 – Galectin-3 Assay Product Overview 93
ARCHITECT c4000 – Methotrexate Assay 94
ARCHITECT c4000 – Methotrexate Assay Product Overview 94
ARCHITECT c4000 Clinical Chemistry Analyzer – Tg Assay 95
ARCHITECT c4000 Clinical Chemistry Analyzer – Tg Assay Product Overview 95
ARCHITECT c4000 System – Ca 72.2 Assay 96
ARCHITECT c4000 System – Ca 72.2 Assay Product Overview 96
ARCHITECT c4000 System – HbSAg Assay 97
ARCHITECT c4000 System – HbSAg Assay Product Overview 97
ARCHITECT c4000 System – High Sensitive Troponin-I Assay 98
ARCHITECT c4000 System – High Sensitive Troponin-I Assay Product Overview 98
ARCHITECT c4000 System – High Sensitive Troponin-I Assay Clinical Trial 99
ARCHITECT c4000 System – Kappa And Lamda Freelite Chains Assay 100
ARCHITECT c4000 System – Kappa And Lamda Freelite Chains Assay Product Overview 100
ARCHITECT c4000 System – NSE Assay 101
ARCHITECT c4000 System – NSE Assay Product Overview 101
ARCHITECT c4000 System – PCT Assay 102
ARCHITECT c4000 System – PCT Assay Product Overview 102
ARCHITECT c4000 System – PIVKA Assay 103
ARCHITECT c4000 System – PIVKA Assay Product Overview 103
ARCHITECT c4000 System – TRAb Assay 104
ARCHITECT c4000 System – TRAb Assay Product Overview 104
ARCHITECT c8000 Integrated System – Galectin-3 Assay 105
ARCHITECT c8000 Integrated System – Galectin-3 Assay Product Overview 105
ARCHITECT c8000 Integrated System – Methotrexate Assay 106
ARCHITECT c8000 Integrated System – Methotrexate Assay Product Overview 106
ARCHITECT c8000 Integrated System – Tg Assay 107
ARCHITECT c8000 Integrated System – Tg Assay Product Overview 107
ARCHITECT c8000 System – Ca 72.2 Assay 108
ARCHITECT c8000 System – Ca 72.2 Assay Product Overview 108
ARCHITECT c8000 System – HbSAg Next Qual Assay 109
ARCHITECT c8000 System – HbSAg Next Qual Assay Product Overview 109
ARCHITECT c8000 System – High Sensitive Troponin-I Assay 110
ARCHITECT c8000 System – High Sensitive Troponin-I Assay Product Overview 110
ARCHITECT c8000 System – High Sensitive Troponin-I Assay Clinical Trial 111
ARCHITECT c8000 System – Kappa And Lamda Freelite Chains Assay 112
ARCHITECT c8000 System – Kappa And Lamda Freelite Chains Assay Product Overview 112
ARCHITECT c8000 System – NSE Assay 113
ARCHITECT c8000 System – NSE Assay Product Overview 113
ARCHITECT c8000 System – PIVKA Assay 114
ARCHITECT c8000 System – PIVKA Assay Product Overview 114
ARCHITECT c8000 System – TRAb Assay 115
ARCHITECT c8000 System – TRAb Assay Product Overview 115
ARCHITECT ci16200 Integrated System – Ca 72.2 Assay 116
ARCHITECT ci16200 Integrated System – Ca 72.2 Assay Product Overview 116
ARCHITECT ci16200 Integrated System – High Sensitive Troponin-I Assay 117
ARCHITECT ci16200 Integrated System – High Sensitive Troponin-I Assay Product Overview 117
ARCHITECT ci16200 Integrated System – High Sensitive Troponin-I Assay Clinical Trial 118
ARCHITECT ci16200 Integrated System – Kappa And Lamda Freelite Chains Assay 119
ARCHITECT ci16200 Integrated System – Kappa And Lamda Freelite Chains Assay Product Overview 119
ARCHITECT ci16200 Integrated System – NSE Assay 120
ARCHITECT ci16200 Integrated System – NSE Assay Product Overview 120
ARCHITECT ci16200 Integrated System – NT Pro BNP Assay 121
ARCHITECT ci16200 Integrated System – NT Pro BNP Assay Product Overview 121
ARCHITECT ci16200 Integrated System – PIVKA Assay 122
ARCHITECT ci16200 Integrated System – PIVKA Assay Product Overview 122
ARCHITECT ci16200 Integrated System – Tg Assay 123
ARCHITECT ci16200 Integrated System – Tg Assay Product Overview 123
ARCHITECT ci16200 Integrated System – TRAb Assay 124
ARCHITECT ci16200 Integrated System – TRAb Assay Product Overview 124
ARCHITECT ci4100 Integrated System – Galectin-3 Assay 125
ARCHITECT ci4100 Integrated System – Galectin-3 Assay Product Overview 125
ARCHITECT ci4100 Integrated System – NSE Assay 126
ARCHITECT ci4100 Integrated System – NSE Assay Product Overview 126
ARCHITECT ci4100 Integrated System – NT Pro BNP Assay 127
ARCHITECT ci4100 Integrated System – NT Pro BNP Assay Product Overview 127
ARCHITECT ci4100 Integrated System – PIVKA Assay 128
ARCHITECT ci4100 Integrated System – PIVKA Assay Product Overview 128
ARCHITECT ci4100 Integrated System – TRAb Assay 129
ARCHITECT ci4100 Integrated System – TRAb Assay Product Overview 129
ARCHITECT ci8200 Integrated System – Ca 72.2 Assay 130
ARCHITECT ci8200 Integrated System – Ca 72.2 Assay Product Overview 130
ARCHITECT ci8200 Integrated System – Kappa And Lamda Freelite Chains Assay 131
ARCHITECT ci8200 Integrated System – Kappa And Lamda Freelite Chains Assay Product Overview 131
ARCHITECT ci8200 Integrated System – NSE Assay 132
ARCHITECT ci8200 Integrated System – NSE Assay Product Overview 132
ARCHITECT ci8200 Integrated System – PIVKA Assay 133
ARCHITECT ci8200 Integrated System – PIVKA Assay Product Overview 133
ARCHITECT ci8200 Integrated System – Tg Assay 134
ARCHITECT ci8200 Integrated System – Tg Assay Product Overview 134
ARCHITECT ci8200 Integrated System – TRAb Assay 135
ARCHITECT ci8200 Integrated System – TRAb Assay Product Overview 135
ARCHITECT i1000SR – NT Pro BNP Assay 136
ARCHITECT i1000SR – NT Pro BNP Assay Product Overview 136
ARCHITECT i1000SR Integrated System – Tg Assay 137
ARCHITECT i1000SR Integrated System – Tg Assay Product Overview 137
ARCHITECT i1000SR System – NSE Assay 138
ARCHITECT i1000SR System – NSE Assay Product Overview 138
ARCHITECT i2000SR Integrated System – Methotrexate Assay 139
ARCHITECT i2000SR Integrated System – Methotrexate Assay Product Overview 139
ARCHITECT i2000SR Integrated System – Neuron-Specific Enolase Assay 140
ARCHITECT i2000SR Integrated System – Neuron-Specific Enolase Assay Product Overview 140
ARCHITECT i2000SR Integrated System – NT Pro BNP Assay 141
ARCHITECT i2000SR Integrated System – NT Pro BNP Assay Product Overview 141
ARCHITECT i4000SR Integrated System – Tg Assay 142
ARCHITECT i4000SR Integrated System – Tg Assay Product Overview 142
ARCHITECT i4000SR System – PIVKA II Assay 143
ARCHITECT i4000SR System – PIVKA II Assay Product Overview 143
ATM Companion Diagnostic Assay – Chronic Lymphocytic Leukemia 144
ATM Companion Diagnostic Assay – Chronic Lymphocytic Leukemia Product Overview 144
AURKA Companion Diagnostic Assay – Bladder Cancer 145
AURKA Companion Diagnostic Assay – Bladder Cancer Product Overview 145
AURKA Companion Diagnostic Assay – Prostate Cancer 146
AURKA Companion Diagnostic Assay – Prostate Cancer Product Overview 146
AXL Companion Diagnostic Assay – Lung Cancer 147
AXL Companion Diagnostic Assay – Lung Cancer Product Overview 147
BCL2 Companion Diagnostic Assay – Leukemia 148
BCL2 Companion Diagnostic Assay – Leukemia Product Overview 148
BCL2 Companion Diagnostic Assay – Lymphoma 149
BCL2 Companion Diagnostic Assay – Lymphoma Product Overview 149
BCL6 Companion Diagnostic Assay – Lymphoma 150
BCL6 Companion Diagnostic Assay – Lymphoma Product Overview 150
BCR/ABL Companion Diagnostic Assay – Acute Lymphocytic Leukemia 151
BCR/ABL Companion Diagnostic Assay – Acute Lymphocytic Leukemia Product Overview 151
BCR/ABL Companion Diagnostic Assay – Acute Myeloid Leukemia 152
BCR/ABL Companion Diagnostic Assay – Acute Myeloid Leukemia Product Overview 152
Biomarker-Based Molecular Diagnostic Test – Prostate Cancer 153
Biomarker-Based Molecular Diagnostic Test – Prostate Cancer Product Overview 153
BRAF Companion Diagnostic Assay – Colorectal Cancer 154
BRAF Companion Diagnostic Assay – Colorectal Cancer Product Overview 154
BRAF Companion Diagnostic Assay – Gastric Cancer 155
BRAF Companion Diagnostic Assay – Gastric Cancer Product Overview 155
BRAF Companion Diagnostic Assay – Glioblastoma 156
BRAF Companion Diagnostic Assay – Glioblastoma Product Overview 156
BRAF Companion Diagnostic Assay – Lung Cancer 157
BRAF Companion Diagnostic Assay – Lung Cancer Product Overview 157
BRAF Companion Diagnostic Assay – Melanoma 158
BRAF Companion Diagnostic Assay – Melanoma Product Overview 158
BRAF Companion Diagnostic Assay – Ovarian Cancer 159
BRAF Companion Diagnostic Assay – Ovarian Cancer Product Overview 159
BRCA1 Companion Diagnostic Assay – Ovarian Cancer 160
BRCA1 Companion Diagnostic Assay – Ovarian Cancer Product Overview 160
BRCA2 Companion Diagnostic Assay – Ovarian Cancer 161
BRCA2 Companion Diagnostic Assay – Ovarian Cancer Product Overview 161
c-KIT Companion Diagnostic Assay – Melanoma 162
c-KIT Companion Diagnostic Assay – Melanoma Product Overview 162
CBFB Companion Diagnostic Assay – Acute Myeloid Leukemia 163
CBFB Companion Diagnostic Assay – Acute Myeloid Leukemia Product Overview 163
CCND1 Companion Diagnostic Assay – Breast Cancer 164
CCND1 Companion Diagnostic Assay – Breast Cancer Product Overview 164
CCND1 Companion Diagnostic Assay – Lymphoma 165
CCND1 Companion Diagnostic Assay – Lymphoma Product Overview 165
CCND1 Companion Diagnostic Assay – Melanoma 166
CCND1 Companion Diagnostic Assay – Melanoma Product Overview 166
CDK6 Companion Diagnostic Assay – Leukemia 167
CDK6 Companion Diagnostic Assay – Leukemia Product Overview 167
CDKN2A Companion Diagnostic Assay – Bladder Cancer 168
CDKN2A Companion Diagnostic Assay – Bladder Cancer Product Overview 168
CDKN2C Companion Diagnostic Assay – Multiple Myeloma 169
CDKN2C Companion Diagnostic Assay – Multiple Myeloma Product Overview 169
CEBPE Companion Diagnostic Assay – Myelodysplastic Syndrome 170
CEBPE Companion Diagnostic Assay – Myelodysplastic Syndrome Product Overview 170
CEP 9 Companion Diagnostic Assay – Multiple Myeloma 171
CEP 9 Companion Diagnostic Assay – Multiple Myeloma Product Overview 171
Chromosome 12 Companion Diagnostic Assay – Chronic Lymphocytic Leukemia 172
Chromosome 12 Companion Diagnostic Assay – Chronic Lymphocytic Leukemia Product Overview 172
Chromosome 17 Companion Diagnostic Assay – Acute Lymphocytic Leukemia 173
Chromosome 17 Companion Diagnostic Assay – Acute Lymphocytic Leukemia Product Overview 173
Chromosome 3 Companion Diagnostic Assay – Cervical Cancer 174
Chromosome 3 Companion Diagnostic Assay – Cervical Cancer Product Overview 174
Chromosome 4 Companion Diagnostic Assay – Acute Lymphocytic Leukemia 175
Chromosome 4 Companion Diagnostic Assay – Acute Lymphocytic Leukemia Product Overview 175
Chromosome 7 Companion Diagnostic Assay – Acute Lymphocytic Leukemia 176
Chromosome 7 Companion Diagnostic Assay – Acute Lymphocytic Leukemia Product Overview 176
Chromosome 7 Companion Diagnostic Assay – Acute Myeloid Leukemia 177
Chromosome 7 Companion Diagnostic Assay – Acute Myeloid Leukemia Product Overview 177
Chromosome 8 Companion Diagnostic Assay – Acute Myeloid Leukemia 178
Chromosome 8 Companion Diagnostic Assay – Acute Myeloid Leukemia Product Overview 178
Chromosome X Companion Diagnostic Assay – Cervical Cancer 179
Chromosome X Companion Diagnostic Assay – Cervical Cancer Product Overview 179
CKS1B Companion Diagnostic Assay – Breast Cancer 180
CKS1B Companion Diagnostic Assay – Breast Cancer Product Overview 180
CKS1B Companion Diagnostic Assay – Multiple Myeloma 181
CKS1B Companion Diagnostic Assay – Multiple Myeloma Product Overview 181
CLL FISH Probe Kit – Ibrutinib 182
CLL FISH Probe Kit – Ibrutinib Product Overview 182
Companion Diagnostic Test – B-cell Lymphoma 183
Companion Diagnostic Test – B-cell Lymphoma Product Overview 183
Companion Diagnostic Test – Cancer 184
Companion Diagnostic Test – Cancer Product Overview 184
COT Companion Diagnostic Assay – Melanoma 185
COT Companion Diagnostic Assay – Melanoma Product Overview 185
CRAF Companion Diagnostic Assay – Melanoma 186
CRAF Companion Diagnostic Assay – Melanoma Product Overview 186
CRLF2 Companion Diagnostic Assay – Acute Lymphocytic Leukemia 187
CRLF2 Companion Diagnostic Assay – Acute Lymphocytic Leukemia Product Overview 187
D13S319/Chromosome 12 Companion Diagnostic Assay – Chronic Lymphocytic Leukemia 188
D13S319/Chromosome 12 Companion Diagnostic Assay – Chronic Lymphocytic Leukemia Product Overview 188
D5S23 Companion Diagnostic Assay – Cervical Cancer 189
D5S23 Companion Diagnostic Assay – Cervical Cancer Product Overview 189
D5S23 Companion Diagnostic Assay – Multiple Myeloma 190
D5S23 Companion Diagnostic Assay – Multiple Myeloma Product Overview 190
D5S721 Companion Diagnostic Assay – Acute Myeloid Leukemia 191
D5S721 Companion Diagnostic Assay – Acute Myeloid Leukemia Product Overview 191
D5S721 Companion Diagnostic Assay – Cervical Cancer 192
D5S721 Companion Diagnostic Assay – Cervical Cancer Product Overview 192
D7S486 Companion Diagnostic Assay – Acute Myeloid Leukemia 193
D7S486 Companion Diagnostic Assay – Acute Myeloid Leukemia Product Overview 193
D7S486 Companion Diagnostic Assay – Myelodysplastic Syndrome 194
D7S486 Companion Diagnostic Assay – Myelodysplastic Syndrome Product Overview 194
D7S552 Companion Diagnostic Assay – Acute Myeloid Leukemia 195
D7S552 Companion Diagnostic Assay – Acute Myeloid Leukemia Product Overview 195
DCC Companion Diagnostic Assay – Colorectal Cancer 196
DCC Companion Diagnostic Assay – Colorectal Cancer Product Overview 196
DDR2 Companion Diagnostic Assay – Lung Cancer 197
DDR2 Companion Diagnostic Assay – Lung Cancer Product Overview 197
DEK/NUP214 Companion Diagnostic Assay – Acute Myeloid Leukemia 198
DEK/NUP214 Companion Diagnostic Assay – Acute Myeloid Leukemia Product Overview 198
del(13q) Companion Diagnostic Assay – Myelodysplastic Syndrome 199
del(13q) Companion Diagnostic Assay – Myelodysplastic Syndrome Product Overview 199
del(17p) Companion Diagnostic Assay – Chronic Lymphocytic Leukemia 200
del(17p) Companion Diagnostic Assay – Chronic Lymphocytic Leukemia Product Overview 200
del(17p) Companion Diagnostic Assay – Multiple Myeloma 201
del(17p) Companion Diagnostic Assay – Multiple Myeloma Product Overview 201
del(5q) Companion Diagnostic Assay – Myelodysplastic Syndrome 202
del(5q) Companion Diagnostic Assay – Myelodysplastic Syndrome Product Overview 202
del(7q) Companion Diagnostic Assay – Myelodysplastic Syndrome 203
del(7q) Companion Diagnostic Assay – Myelodysplastic Syndrome Product Overview 203
del(9q) Companion Diagnostic Assay – Myelodysplastic Syndrome 204
del(9q) Companion Diagnostic Assay – Myelodysplastic Syndrome Product Overview 204
Diagnostic Assay – MTb Drug Resistance 205
Diagnostic Assay – MTb Drug Resistance Product Overview 205
DOT1L Companion Diagnostic Test 206
DOT1L Companion Diagnostic Test Product Overview 206
DPP4 Based Companion Diagnostic Assay – Asthma 207
DPP4 Based Companion Diagnostic Assay – Asthma Product Overview 207
E2A/PDX1 Companion Diagnostic Assay – Acute Lymphocytic Leukemia 208
E2A/PDX1 Companion Diagnostic Assay – Acute Lymphocytic Leukemia Product Overview 208
EGFR Companion Diagnostic Assay – Biliary Cancer 209
EGFR Companion Diagnostic Assay – Biliary Cancer Product Overview 209
EGFR Companion Diagnostic Assay – Brain Cancer 210
EGFR Companion Diagnostic Assay – Brain Cancer Product Overview 210
EGFR Companion Diagnostic Assay – Glioblastoma 211
EGFR Companion Diagnostic Assay – Glioblastoma Product Overview 211
EGFR Companion Diagnostic Assay – Lung Cancer 212
EGFR Companion Diagnostic Assay – Lung Cancer Product Overview 212
EGFRvIII Companion Diagnostic Assay – Glioblastoma 213
EGFRvIII Companion Diagnostic Assay – Glioblastoma Product Overview 213
EGFRvIII Companion Diagnostic Assay – Lung Cancer 214
EGFRvIII Companion Diagnostic Assay – Lung Cancer Product Overview 214
EGR1 Companion Diagnostic Assay – Acute Myeloid Leukemia 215
EGR1 Companion Diagnostic Assay – Acute Myeloid Leukemia Product Overview 215
EGR1/D5S23 Companion Diagnostic Assay – Myelodysplastic Syndrome 216
EGR1/D5S23 Companion Diagnostic Assay – Myelodysplastic Syndrome Product Overview 216
EML4 Companion Diagnostic Assay – Lung Cancer 217
EML4 Companion Diagnostic Assay – Lung Cancer Product Overview 217
ERBB3 Companion Diagnostic Assay – Bladder Cancer 218
ERBB3 Companion Diagnostic Assay – Bladder Cancer Product Overview 218
ERG Companion Diagnostic Assay – Prostate Cancer 219
ERG Companion Diagnostic Assay – Prostate Cancer Product Overview 219
ETV Companion Diagnostic Assay – Sarcoma 220
ETV Companion Diagnostic Assay – Sarcoma Product Overview 220
ETV1 Companion Diagnostic Assay – Prostate Cancer 221
ETV1 Companion Diagnostic Assay – Prostate Cancer Product Overview 221
ETV6/RUNX1 Companion Diagnostic Assay – Acute Lymphocytic Leukemia 222
ETV6/RUNX1 Companion Diagnostic Assay – Acute Lymphocytic Leukemia Product Overview 222
FGFR1 Companion Diagnostic Assay – Breast Cancer 223
FGFR1 Companion Diagnostic Assay – Breast Cancer Product Overview 223
FGFR1 Companion Diagnostic Assay – Lung Cancer 224
FGFR1 Companion Diagnostic Assay – Lung Cancer Product Overview 224
FGFR1 Companion Diagnostic Assay – Prostate Cancer 225
FGFR1 Companion Diagnostic Assay – Prostate Cancer Product Overview 225
FGFR2 Companion Diagnostic Assay – Breast Cancer 226
FGFR2 Companion Diagnostic Assay – Breast Cancer Product Overview 226
FGFR2 Companion Diagnostic Assay – Colorectal Cancer 227
FGFR2 Companion Diagnostic Assay – Colorectal Cancer Product Overview 227
FGFR2 Companion Diagnostic Assay – Gastric Cancer 228
FGFR2 Companion Diagnostic Assay – Gastric Cancer Product Overview 228
FGFR2 Companion Diagnostic Assay – Lung Cancer 229
FGFR2 Companion Diagnostic Assay – Lung Cancer Product Overview 229
FGFR3 Companion Diagnostic Assay – Bladder Cancer 230
FGFR3 Companion Diagnostic Assay – Bladder Cancer Product Overview 230
FGFR3-TACC3 Companion Diagnostic Assay – Bladder Cancer 231
FGFR3-TACC3 Companion Diagnostic Assay – Bladder Cancer Product Overview 231
FGFR3-TACC3 Companion Diagnostic Assay – Lung Cancer 232
FGFR3-TACC3 Companion Diagnostic Assay – Lung Cancer Product Overview 232
GNA11 Companion Diagnostic Assay – Melanoma 233
GNA11 Companion Diagnostic Assay – Melanoma Product Overview 233
GNAQ Companion Diagnostic Assay – Melanoma 234
GNAQ Companion Diagnostic Assay – Melanoma Product Overview 234
H3F3A Companion Diagnostic Assay – Glioblastoma 235
H3F3A Companion Diagnostic Assay – Glioblastoma Product Overview 235
HER2 Companion Diagnostic Assay – Bladder Cancer 236
HER2 Companion Diagnostic Assay – Bladder Cancer Product Overview 236
HER2 Companion Diagnostic Assay – Breast Cancer 237
HER2 Companion Diagnostic Assay – Breast Cancer Product Overview 237
HER2 Companion Diagnostic Assay – Gastric Cancer 238
HER2 Companion Diagnostic Assay – Gastric Cancer Product Overview 238
HER2 Companion Diagnostic Assay – Lung Cancer 239
HER2 Companion Diagnostic Assay – Lung Cancer Product Overview 239
HER3 Companion Diagnostic Assay – Lung Cancer 240
HER3 Companion Diagnostic Assay – Lung Cancer Product Overview 240
Heregulin Companion Diagnostic Assay – Lung Cancer 241
Heregulin Companion Diagnostic Assay – Lung Cancer Product Overview 241
HIF-1alpha Companion Diagnostic Assay – Renal Cancer 242
HIF-1alpha Companion Diagnostic Assay – Renal Cancer Product Overview 242
HOX11L2/TLX3 Companion Diagnostic Assay – Acute Lymphocytic Leukemia 243
HOX11L2/TLX3 Companion Diagnostic Assay – Acute Lymphocytic Leukemia Product Overview 243
Hyperdiploidy Companion Diagnostic Assay – Multiple Myeloma 244
Hyperdiploidy Companion Diagnostic Assay – Multiple Myeloma Product Overview 244
i(17q) Companion Diagnostic Assay – Myelodysplastic Syndrome 245
i(17q) Companion Diagnostic Assay – Myelodysplastic Syndrome Product Overview 245
IDH1 Companion Diagnostic Assay – Biliary Cancer 246
IDH1 Companion Diagnostic Assay – Biliary Cancer Product Overview 246
IDH1 Companion Diagnostic Assay – Glioblastoma 247
IDH1 Companion Diagnostic Assay – Glioblastoma Product Overview 247
IDH1 Companion Diagnostic Assay – Leukemia 248
IDH1 Companion Diagnostic Assay – Leukemia Product Overview 248
IDH1 Companion Diagnostic Assay – Sarcoma 249
IDH1 Companion Diagnostic Assay – Sarcoma Product Overview 249
IDH2 Companion Diagnostic Assay – Glioblastoma 250
IDH2 Companion Diagnostic Assay – Glioblastoma Product Overview 250
IDH2 Companion Diagnostic Assay – Sarcoma 251
IDH2 Companion Diagnostic Assay – Sarcoma Product Overview 251
idic(Xq) Companion Diagnostic Assay – Myelodysplastic Syndrome 252
idic(Xq) Companion Diagnostic Assay – Myelodysplastic Syndrome Product Overview 252
IGF1R Companion Diagnostic Assay – Breast Cancer 253
IGF1R Companion Diagnostic Assay – Breast Cancer Product Overview 253
IGF1R Companion Diagnostic Assay – Lung Cancer 254
IGF1R Companion Diagnostic Assay – Lung Cancer Product Overview 254
IGF1R Companion Diagnostic Assay – Melanoma 255
IGF1R Companion Diagnostic Assay – Melanoma Product Overview 255
IGF1R Companion Diagnostic Assay – Prostate Cancer 256
IGF1R Companion Diagnostic Assay – Prostate Cancer Product Overview 256
IGFR1 Companion Diagnostic Assay – Solid Tumor 257
IGFR1 Companion Diagnostic Assay – Solid Tumor Product Overview 257
IGH/CCND1 t(11;14) Companion Diagnostic Assay – Chronic Lymphocytic Leukemia 258
IGH/CCND1 t(11;14) Companion Diagnostic Assay – Chronic Lymphocytic Leukemia Product Overview 258
IGH/CCND1 t(11;14) Companion Diagnostic Assay – Multiple Myeloma 259
IGH/CCND1 t(11;14) Companion Diagnostic Assay – Multiple Myeloma Product Overview 259
IGH/CCND3 t(6;14) Companion Diagnostic Assay – Multiple Myeloma 260
IGH/CCND3 t(6;14) Companion Diagnostic Assay – Multiple Myeloma Product Overview 260
IGH/FGFR3 t(4;14) Companion Diagnostic Assay – Multiple Myeloma 261
IGH/FGFR3 t(4;14) Companion Diagnostic Assay – Multiple Myeloma Product Overview 261
IGH/MAF t(14;16) Companion Diagnostic Assay – Multiple Myeloma 262
IGH/MAF t(14;16) Companion Diagnostic Assay – Multiple Myeloma Product Overview 262
IGH/MAFB t(14;20) Companion Diagnostic Assay – Multiple Myeloma 263
IGH/MAFB t(14;20) Companion Diagnostic Assay – Multiple Myeloma Product Overview 263
IGH/MALT t(14;18) Companion Diagnostic Assay – Chronic Lymphocytic Leukemia 264
IGH/MALT t(14;18) Companion Diagnostic Assay – Chronic Lymphocytic Leukemia Product Overview 264
IGH/MALT t(14;18) Companion Diagnostic Assay – Lymphoma 265
IGH/MALT t(14;18) Companion Diagnostic Assay – Lymphoma Product Overview 265
IGH/MYC t(8;14) Companion Diagnostic Assay – Lymphoma 266
IGH/MYC t(8;14) Companion Diagnostic Assay – Lymphoma Product Overview 266
IKZF1 Companion Diagnostic Assay – Acute Lymphocytic Leukemia 267
IKZF1 Companion Diagnostic Assay – Acute Lymphocytic Leukemia Product Overview 267
inv(16) Companion Diagnostic Assay – Myelodysplastic Syndrome 268
inv(16) Companion Diagnostic Assay – Myelodysplastic Syndrome Product Overview 268
inv(17q) Companion Diagnostic Assay – Myelodysplastic Syndrome 269
inv(17q) Companion Diagnostic Assay – Myelodysplastic Syndrome Product Overview 269
inv(3) Companion Diagnostic Assay – Myelodysplastic Syndrome 270
inv(3) Companion Diagnostic Assay – Myelodysplastic Syndrome Product Overview 270
JAK2 Companion Diagnostic Assay – Breast Cancer 271
JAK2 Companion Diagnostic Assay – Breast Cancer Product Overview 271
KEAP1 Companion Diagnostic Assay – Lung Cancer 272
KEAP1 Companion Diagnostic Assay – Lung Cancer Product Overview 272
KIF5B Companion Diagnostic Assay – Lung Cancer 273
KIF5B Companion Diagnostic Assay – Lung Cancer Product Overview 273
KIT Companion Diagnostic Assay – Gastric Cancer 274
KIT Companion Diagnostic Assay – Gastric Cancer Product Overview 274
KIT Companion Diagnostic Assay – Glioblastoma 275
KIT Companion Diagnostic Assay – Glioblastoma Product Overview 275
KRAS Companion Diagnostic Assay – Colorectal Cancer 276
KRAS Companion Diagnostic Assay – Colorectal Cancer Product Overview 276
KRAS Companion Diagnostic Assay – Lung Cancer 277
KRAS Companion Diagnostic Assay – Lung Cancer Product Overview 277
KRAS Companion Diagnostic Assay – Melanoma 278
KRAS Companion Diagnostic Assay – Melanoma Product Overview 278
KRAS Companion Diagnostic Assay – Ovarian Cancer 279
KRAS Companion Diagnostic Assay – Ovarian Cancer Product Overview 279
KRAS Companion Diagnostic Assay – Solid Tumors 280
KRAS Companion Diagnostic Assay – Solid Tumors Product Overview 280
LKB1 Companion Diagnostic Assay – Lung Cancer 281
LKB1 Companion Diagnostic Assay – Lung Cancer Product Overview 281
m-PIMA HIV-1/2 Viral Load Test 282
m-PIMA HIV-1/2 Viral Load Test Product Overview 282
m2000 RealTime System – AG-120 Companion Diagnostic Test 283
m2000 RealTime System – AG-120 Companion Diagnostic Test Product Overview 283
m2000 RealTime System – Enasidenib Companion Diagnostic Test 284
m2000 RealTime System – Enasidenib Companion Diagnostic Test Product Overview 284
MAGE-A3 Companion Diagnostic Assay – Melanoma 285
MAGE-A3 Companion Diagnostic Assay – Melanoma Product Overview 285
MAGE-A3 Companion Diagnostic Assay – NSCLC 286
MAGE-A3 Companion Diagnostic Assay – NSCLC Product Overview 286
MALT1 Companion Diagnostic Assay – Lymphoma 287
MALT1 Companion Diagnostic Assay – Lymphoma Product Overview 287
MAP3K1 Companion Diagnostic Assay – Breast Cancer 288
MAP3K1 Companion Diagnostic Assay – Breast Cancer Product Overview 288
MCL1 Companion Diagnostic Assay – Biliary Cancer 289
MCL1 Companion Diagnostic Assay – Biliary Cancer Product Overview 289
MCL1 Companion Diagnostic Assay – Leukemia 290
MCL1 Companion Diagnostic Assay – Leukemia Product Overview 290
MDM2 Companion Diagnostic Assay – Prostate Cancer 291
MDM2 Companion Diagnostic Assay – Prostate Cancer Product Overview 291
MDM2/CEP12 Companion Diagnostic Assay – Sarcomas 292
MDM2/CEP12 Companion Diagnostic Assay – Sarcomas Product Overview 292
MEK1 Companion Diagnostic Assay – Lung Cancer 293
MEK1 Companion Diagnostic Assay – Lung Cancer Product Overview 293
MEK1 Companion Diagnostic Assay – Melanoma 294
MEK1 Companion Diagnostic Assay – Melanoma Product Overview 294
MET Companion Diagnostic Assay – Brain Cancer 295
MET Companion Diagnostic Assay – Brain Cancer Product Overview 295
MET Companion Diagnostic Assay – Breast Cancer 296
MET Companion Diagnostic Assay – Breast Cancer Product Overview 296
MET Companion Diagnostic Assay – Colorectal Cancer 297
MET Companion Diagnostic Assay – Colorectal Cancer Product Overview 297
MET Companion Diagnostic Assay – Gastric Cancer 298
MET Companion Diagnostic Assay – Gastric Cancer Product Overview 298
MET Companion Diagnostic Assay – Kidney Cancer 299
MET Companion Diagnostic Assay – Kidney Cancer Product Overview 299
MET Companion Diagnostic Assay – Lung Cancer 300
MET Companion Diagnostic Assay – Lung Cancer Product Overview 300
MET Companion Diagnostic Assay – Ovarian Cancer 301
MET Companion Diagnostic Assay – Ovarian Cancer Product Overview 301
MGMT Companion Diagnostic Assay – Glioblastoma 302
MGMT Companion Diagnostic Assay – Glioblastoma Product Overview 302
MLL Companion Diagnostic Assay – Acute Lymphocytic Leukemia 303
MLL Companion Diagnostic Assay – Acute Lymphocytic Leukemia Product Overview 303
MLL Companion Diagnostic Assay – Acute Myeloid Leukemia 304
MLL Companion Diagnostic Assay – Acute Myeloid Leukemia Product Overview 304
MLL Companion Diagnostic Assay – Leukemia 305
MLL Companion Diagnostic Assay – Leukemia Product Overview 305
MUC1 Companion Diagnostic Assay – Ovarian Cancer 306
MUC1 Companion Diagnostic Assay – Ovarian Cancer Product Overview 306
MYB Companion Diagnostic Assay – Chronic Lymphocytic Leukemia 307
MYB Companion Diagnostic Assay – Chronic Lymphocytic Leukemia Product Overview 307
MYB Companion Diagnostic Assay – Melanoma 308
MYB Companion Diagnostic Assay – Melanoma Product Overview 308
MYC Companion Diagnostic Assay – Acute Lymphocytic Leukemia 309
MYC Companion Diagnostic Assay – Acute Lymphocytic Leukemia Product Overview 309
MYC Companion Diagnostic Assay – Chronic Lymphocytic Leukemia 310
MYC Companion Diagnostic Assay – Chronic Lymphocytic Leukemia Product Overview 310
MYC Companion Diagnostic Assay – Lymphoma 311
MYC Companion Diagnostic Assay – Lymphoma Product Overview 311
MYC Companion Diagnostic Assay – Multiple Myeloma 312
MYC Companion Diagnostic Assay – Multiple Myeloma Product Overview 312
MYC Companion Diagnostic Assay – Prostate Cancer 313
MYC Companion Diagnostic Assay – Prostate Cancer Product Overview 313
MYCN Companion Diagnostic Assay – Prostate Cancer 314
MYCN Companion Diagnostic Assay – Prostate Cancer Product Overview 314
MYD88 Companion Diagnostic Assay – Lymphoma 315
MYD88 Companion Diagnostic Assay – Lymphoma Product Overview 315
MYF11/CBFB inv (16)/t(16;16) Companion Diagnostic Assay – Acute Myeloid Leukemia 316
MYF11/CBFB inv (16)/t(16;16) Companion Diagnostic Assay – Acute Myeloid Leukemia Product Overview 316
Next Generation Blood Screening System 317
Next Generation Blood Screening

List of Tables
Abbott Diagnostics Pipeline Products and Ongoing Clinical Trials Overview 28
Abbott Diagnostics Pipeline Products by Equipment Type 29
Abbott Diagnostics Pipeline Products by Indication 30
Abbott Diagnostics Ongoing Clinical Trials by Trial Status 30
Abbott Diagnostics, Key Facts 32
Abbott Diagnostics, Major Products and Services 33
Abbott Diagnostics Number of Pipeline Products by Development Stage 41
Abbott Diagnostics Pipeline Products Summary by Development Stage 42
Abbott Diagnostics Ongoing Clinical Trials by Trial Status 57
Abbott Diagnostics Ongoing Clinical Trials Summary 58
13q14.3 Companion Diagnostic Assay - Chronic Lymphocytic Leukemia - Product Status 59
13q14.3 Companion Diagnostic Assay - Chronic Lymphocytic Leukemia - Product Description 59
ACTN4 Companion Diagnostic Assay - Lung Cancer - Product Status 60
ACTN4 Companion Diagnostic Assay - Lung Cancer - Product Description 60
AKT Companion Diagnostic Assay - Breast Cancer - Product Status 61
AKT Companion Diagnostic Assay - Breast Cancer - Product Description 61
AKT Companion Diagnostic Assay - Colorectal Cancer - Product Status 62
AKT Companion Diagnostic Assay - Colorectal Cancer - Product Description 62
AKT Companion Diagnostic Assay - Renal Cancer - Product Status 63
AKT Companion Diagnostic Assay - Renal Cancer - Product Description 63
Alere i Strep A 2 - Product Status 64
Alere i Strep A 2 - Product Description 64
Alinity c System - Product Status 65
Alinity c System - Product Description 65
Alinity ci - Calcium - Product Status 66
Alinity ci - Calcium - Product Description 66
Alinity ci - Cancer - Product Status 67
Alinity ci - Cancer - Product Description 67
Alinity ci - Cardiac Diseases - Product Status 68
Alinity ci - Cardiac Diseases - Product Description 68
Alinity ci - Glucose - Product Status 69
Alinity ci - Glucose - Product Description 69
Alinity ci - Hormone Deficiency - Product Status 70
Alinity ci - Hormone Deficiency - Product Description 70
Alinity ci - Infectious Diseases - Product Status 71
Alinity ci - Infectious Diseases - Product Description 71
Alinity ci - Potassium - Product Status 72
Alinity ci - Potassium - Product Description 72
Alinity ci - Sodium - Product Status 73
Alinity ci - Sodium - Product Description 73
Alinity ci - TDM - Product Status 74
Alinity ci - TDM - Product Description 74
Alinity ci - Thyroid Disease - Product Status 75
Alinity ci - Thyroid Disease - Product Description 75
Alinity i System - Product Status 76
Alinity i System - Product Description 76
Alinity PRO - Product Status 77
Alinity PRO - Product Description 77
Alinity s System - Product Status 78
Alinity s System - Product Description 78
ALK Companion Diagnostic Assay - Colorectal Cancer - Product Status 79
ALK Companion Diagnostic Assay - Colorectal Cancer - Product Description 79
ALK Companion Diagnostic Assay - Lung Cancer - Product Status 80
ALK Companion Diagnostic Assay - Lung Cancer - Product Description 80
AR Companion Diagnostic Assay - Breast Cancer - Product Status 81
AR Companion Diagnostic Assay - Breast Cancer - Product Description 81
AR Companion Diagnostic Assay - Prostate Cancer - Product Status 82
AR Companion Diagnostic Assay - Prostate Cancer - Product Description 82
ARCHITECT c16000 Integrated System - Galectin-3 Assay - Product Status 83
ARCHITECT c16000 Integrated System - Galectin-3 Assay - Product Description 83
ARCHITECT c16000 System - Ca 72.2 Assay - Product Status 84
ARCHITECT c16000 System - Ca 72.2 Assay - Product Description 84
ARCHITECT c16000 System - HbSAg Assay - Product Status 85
ARCHITECT c16000 System - HbSAg Assay - Product Description 85
ARCHITECT c16000 System - High Sensitive Troponin - I Assay - Product Status 86
ARCHITECT c16000 System - High Sensitive Troponin - I Assay - Product Description 86
ARCHITECT c16000 System - High Sensitive Troponin - I Assay - Australian New Zealand Acute Chest Pain (ANZACP) Registry: A Registry of the Investigation, Management and Outcomes of Patients Presenting to Two Australasian Hospitals with Chest Pain of Possible Cardiac Origin 87
ARCHITECT c16000 System - Methotrexate Assay - Product Status 88
ARCHITECT c16000 System - Methotrexate Assay - Product Description 88
ARCHITECT c16000 System - NSE Assay - Product Status 89
ARCHITECT c16000 System - NSE Assay - Product Description 89
ARCHITECT c16000 System - PCT Assay - Product Status 90
ARCHITECT c16000 System - PCT Assay - Product Description 90
ARCHITECT c16000 System - PIVKA Assay - Product Status 91
ARCHITECT c16000 System - PIVKA Assay - Product Description 91
ARCHITECT c16000 System - Tg Assay - Product Status 92
ARCHITECT c16000 System - Tg Assay - Product Description 92
ARCHITECT c4000 - Galectin-3 Assay - Product Status 93
ARCHITECT c4000 - Galectin-3 Assay - Product Description 93
ARCHITECT c4000 - Methotrexate Assay - Product Status 94
ARCHITECT c4000 - Methotrexate Assay - Product Description 94
ARCHITECT c4000 Clinical Chemistry Analyzer - Tg Assay - Product Status 95
ARCHITECT c4000 Clinical Chemistry Analyzer - Tg Assay - Product Description 95
ARCHITECT c4000 System - Ca 72.2 Assay - Product Status 96
ARCHITECT c4000 System - Ca 72.2 Assay - Product Description 96
ARCHITECT c4000 System - HbSAg Assay - Product Status 97
ARCHITECT c4000 System - HbSAg Assay - Product Description 97
ARCHITECT c4000 System - High Sensitive Troponin-I Assay - Product Status 98
ARCHITECT c4000 System - High Sensitive Troponin-I Assay - Product Description 98
ARCHITECT c4000 System - High Sensitive Troponin-I Assay - Australian New Zealand Acute Chest Pain (ANZACP) Registry: A Registry of the Investigation, Management and Outcomes of Patients Presenting to Two Australasian Hospitals with Chest Pain of Possible Cardiac Origin 99
ARCHITECT c4000 System - Kappa And Lamda Freelite Chains Assay - Product Status 100
ARCHITECT c4000 System - Kappa And Lamda Freelite Chains Assay - Product Description 100
ARCHITECT c4000 System - NSE Assay - Product Status 101
ARCHITECT c4000 System - NSE Assay - Product Description 101
ARCHITECT c4000 System - PCT Assay - Product Status 102
ARCHITECT c4000 System - PCT Assay - Product Description 102
ARCHITECT c4000 System - PIVKA Assay - Product Status 103
ARCHITECT c4000 System - PIVKA Assay - Product Description 103
ARCHITECT c4000 System - TRAb Assay - Product Status 104
ARCHITECT c4000 System - TRAb Assay - Product Description 104
ARCHITECT c8000 Integrated System - Galectin-3 Assay - Product Status 105
ARCHITECT c8000 Integrated System - Galectin-3 Assay - Product Description 105
ARCHITECT c8000 Integrated System - Methotrexate Assay - Product Status 106
ARCHITECT c8000 Integrated System - Methotrexate Assay - Product Description 106
ARCHITECT c8000 Integrated System - Tg Assay - Product Status 107
ARCHITECT c8000 Integrated System - Tg Assay - Product Description 107
ARCHITECT c8000 System - Ca 72.2 Assay - Product Status 108
ARCHITECT c8000 System - Ca 72.2 Assay - Product Description 108
ARCHITECT c8000 System - HbSAg Next Qual Assay - Product Status 109
ARCHITECT c8000 System - HbSAg Next Qual Assay - Product Description 109
ARCHITECT c8000 System - High Sensitive Troponin-I Assay - Product Status 110
ARCHITECT c8000 System - High Sensitive Troponin-I Assay - Product Description 110
ARCHITECT c8000 System - High Sensitive Troponin-I Assay - Australian New Zealand Acute Chest Pain (ANZACP) Registry: A Registry of the Investigation, Management and Outcomes of Patients Presenting to Two Australasian Hospitals with Chest Pain of Possible Cardiac Origin 111
ARCHITECT c8000 System - Kappa And Lamda Freelite Chains Assay - Product Status 112
ARCHITECT c8000 System - Kappa And Lamda Freelite Chains Assay - Product Description 112
ARCHITECT c8000 System - NSE Assay - Product Status 113
ARCHITECT c8000 System - NSE Assay - Product Description 113
ARCHITECT c8000 System - PIVKA Assay - Product Status 114
ARCHITECT c8000 System - PIVKA Assay - Product Description 114
ARCHITECT c8000 System - TRAb Assay - Product Status 115
ARCHITECT c8000 System - TRAb Assay - Product Description 115
ARCHITECT ci16200 Integrated System - Ca 72.2 Assay - Product Status 116
ARCHITECT ci16200 Integrated System - Ca 72.2 Assay - Product Description 116
ARCHITECT ci16200 Integrated System - High Sensitive Troponin-I Assay - Product Status 117
ARCHITECT ci16200 Integrated System - High Sensitive Troponin-I Assay - Product Description 117
ARCHITECT ci16200 Integrated System - High Sensitive Troponin-I Assay - Australian New Zealand Acute Chest Pain (ANZACP) Registry: A Registry of the Investigation, Management and Outcomes of Patients Presenting to Two Australasian Hospitals with Chest Pain of Possible Cardiac Origin 118
ARCHITECT ci16200 Integrated System - Kappa And Lamda Freelite Chains Assay - Product Status 119
ARCHITECT ci16200 Integrated System - Kappa And Lamda Freelite Chains Assay - Product Description 119
ARCHITECT ci16200 Integrated System - NSE Assay - Product Status 120
ARCHITECT ci16200 Integrated System - NSE Assay - Product Description 120
ARCHITECT ci16200 Integrated System - NT Pro BNP Assay - Product Status 121
ARCHITECT ci16200 Integrated System - NT Pro BNP Assay - Product Description 121
ARCHITECT ci16200 Integrated System - PIVKA Assay - Product Status 122
ARCHITECT ci16200 Integrated System - PIVKA Assay - Product Description 122
ARCHITECT ci16200 Integrated System - Tg Assay - Product Status 123
ARCHITECT ci16200 Integrated System - Tg Assay - Product Description 123
ARCHITECT ci16200 Integrated System - TRAb Assay - Product Status 124
ARCHITECT ci16200 Integrated System - TRAb Assay - Product Description 124
ARCHITECT ci4100 Integrated System - Galectin-3 Assay - Product Status 125
ARCHITECT ci4100 Integrated System - Galectin-3 Assay - Product Description 125
ARCHITECT ci4100 Integrated System - NSE Assay - Product Status 126
ARCHITECT ci4100 Integrated System - NSE Assay - Product Description 126
ARCHITECT ci4100 Integrated System - NT Pro BNP Assay - Product Status 127
ARCHITECT ci4100 Integrated System - NT Pro BNP Assay - Product Description 127
ARCHITECT ci4100 Integrated System - PIVKA Assay - Product Status 128
ARCHITECT ci4100 Integrated System - PIVKA Assay - Product Description 128
ARCHITECT ci4100 Integrated System - TRAb Assay - Product Status 129
ARCHITECT ci4100 Integrated System - TRAb Assay - Product Description 129
ARCHITECT ci8200 Integrated System - Ca 72.2 Assay - Product Status 130
ARCHITECT ci8200 Integrated System - Ca 72.2 Assay - Product Description 130
ARCHITECT ci8200 Integrated System - Kappa And Lamda Freelite Chains Assay - Product Status 131
ARCHITECT ci8200 Integrated System - Kappa And Lamda Freelite Chains Assay - Product Description 131
ARCHITECT ci8200 Integrated System - NSE Assay - Product Status 132
ARCHITECT ci8200 Integrated System - NSE Assay - Product Description 132
ARCHITECT ci8200 Integrated System - PIVKA Assay - Product Status 133
ARCHITECT ci8200 Integrated System - PIVKA Assay - Product Description 133
ARCHITECT ci8200 Integrated System - Tg Assay - Product Status 134
ARCHITECT ci8200 Integrated System - Tg Assay - Product Description 134
ARCHITECT ci8200 Integrated System - TRAb Assay - Product Status 135
ARCHITECT ci8200 Integrated System - TRAb Assay - Product Description 135
ARCHITECT i1000SR - NT Pro BNP Assay - Product Status 136
ARCHITECT i1000SR - NT Pro BNP Assay - Product Description 136
ARCHITECT i1000SR Integrated System - Tg Assay - Product Status 137
ARCHITECT i1000SR Integrated System - Tg Assay - Product Description 137
ARCHITECT i1000SR System - NSE Assay - Product Status 138
ARCHITECT i1000SR System - NSE Assay - Product Description 138
ARCHITECT i2000SR Integrated System - Methotrexate Assay - Product Status 139
ARCHITECT i2000SR Integrated System - Methotrexate Assay - Product Description 139
ARCHITECT i2000SR Integrated System - Neuron-Specific Enolase Assay - Product Status 140
ARCHITECT i2000SR Integrated System - Neuron-Specific Enolase Assay - Product Description 140
ARCHITECT i2000SR Integrated System - NT Pro BNP Assay - Product Status 141
ARCHITECT i2000SR Integrated System - NT Pro BNP Assay - Product Description 141
ARCHITECT i4000SR Integrated System - Tg Assay - Product Status 142
ARCHITECT i4000SR Integrated System - Tg Assay - Product Description 142
ARCHITECT i4000SR System - PIVKA II Assay - Product Status 143
ARCHITECT i4000SR System - PIVKA II Assay - Product Description 143
ATM Companion Diagnostic Assay - Chronic Lymphocytic Leukemia - Product Status 144
ATM Companion Diagnostic Assay - Chronic Lymphocytic Leukemia - Product Description 144
AURKA Companion Diagnostic Assay - Bladder Cancer - Product Status 145
AURKA Companion Diagnostic Assay - Bladder Cancer - Product Description 145
AURKA Companion Diagnostic Assay - Prostate Cancer - Product Status 146
AURKA Companion Diagnostic Assay - Prostate Cancer - Product Description 146
AXL Companion Diagnostic Assay - Lung Cancer - Product Status 147
AXL Companion Diagnostic Assay - Lung Cancer - Product Description 147
BCL2 Companion Diagnostic Assay - Leukemia - Product Status 148
BCL2 Companion Diagnostic Assay - Leukemia - Product Description 148
BCL2 Companion Diagnostic Assay - Lymphoma - Product Status 149
BCL2 Companion Diagnostic Assay - Lymphoma - Product Description 149
BCL6 Companion Diagnostic Assay - Lymphoma - Product Status 150
BCL6 Companion Diagnostic Assay - Lymphoma - Product Description 150
BCR/ABL Companion Diagnostic Assay - Acute Lymphocytic Leukemia - Product Status 151
BCR/ABL Companion Diagnostic Assay - Acute Lymphocytic Leukemia - Product Description 151
BCR/ABL Companion Diagnostic Assay - Acute Myeloid Leukemia - Product Status 152
BCR/ABL Companion Diagnostic Assay - Acute Myeloid Leukemia - Product Description 152
Biomarker-Based Molecular Diagnostic Test - Prostate Cancer - Product Status 153
Biomarker-Based Molecular Diagnostic Test - Prostate Cancer - Product Description 153
BRAF Companion Diagnostic Assay - Colorectal Cancer - Product Status 154
BRAF Companion Diagnostic Assay - Colorectal Cancer - Product Description 154
BRAF Companion Diagnostic Assay - Gastric Cancer - Product Status 155
BRAF Companion Diagnostic Assay - Gastric Cancer - Product Description 155
BRAF Companion Diagnostic Assay - Glioblastoma - Product Status 156
BRAF Companion Diagnostic Assay - Glioblastoma - Product Description 156
BRAF Companion Diagnostic Assay - Lung Cancer - Product Status 157
BRAF Companion Diagnostic Assay - Lung Cancer - Product Description 157
BRAF Companion Diagnostic Assay - Melanoma - Product Status 158
BRAF Companion Diagnostic Assay - Melanoma - Product Description 158
BRAF Companion Diagnostic Assay - Ovarian Cancer - Product Status 159
BRAF Companion Diagnostic Assay - Ovarian Cancer - Product Description 159
BRCA1 Companion Diagnostic Assay - Ovarian Cancer - Product Status 160
BRCA1 Companion Diagnostic Assay - Ovarian Cancer - Product Description 160
BRCA2 Companion Diagnostic Assay - Ovarian Cancer - Product Status 161
BRCA2 Companion Diagnostic Assay - Ovarian Cancer - Product Description 161
c-KIT Companion Diagnostic Assay - Melanoma - Product Status 162
c-KIT Companion Diagnostic Assay - Melanoma - Product Description 162
CBFB Companion Diagnostic Assay - Acute Myeloid Leukemia - Product Status 163
CBFB Companion Diagnostic Assay - Acute Myeloid Leukemia - Product Description 163
CCND1 Companion Diagnostic Assay - Breast Cancer - Product Status 164
CCND1 Companion Diagnostic Assay - Breast Cancer - Product Description 164
CCND1 Companion Diagnostic Assay - Lymphoma - Product Status 165
CCND1 Companion Diagnostic Assay - Lymphoma - Product Description 165
CCND1 Companion Diagnostic Assay - Melanoma - Product Status 166
CCND1 Companion Diagnostic Assay - Melanoma - Product Description 166
CDK6 Companion Diagnostic Assay - Leukemia - Product Status 167
CDK6 Companion Diagnostic Assay - Leukemia - Product Description 167
CDKN2A Companion Diagnostic Assay - Bladder Cancer - Product Status 168
CDKN2A Companion Diagnostic Assay - Bladder Cancer - Product Description 168
CDKN2C Companion Diagnostic Assay - Multiple Myeloma - Product Status 169
CDKN2C Companion Diagnostic Assay - Multiple Myeloma - Product Description 169
CEBPE Companion Diagnostic Assay - Myelodysplastic Syndrome - Product Status 170
CEBPE Companion Diagnostic Assay - Myelodysplastic Syndrome - Product Description 170
CEP 9 Companion Diagnostic Assay - Multiple Myeloma - Product Status 171
CEP 9 Companion Diagnostic Assay - Multiple Myeloma - Product Description 171
Chromosome 12 Companion Diagnostic Assay - Chronic Lymphocytic Leukemia - Product Status 172
Chromosome 12 Companion Diagnostic Assay - Chronic Lymphocytic Leukemia - Product Description 172
Chromosome 17 Companion Diagnostic Assay - Acute Lymphocytic Leukemia - Product Status 173
Chromosome 17 Companion Diagnostic Assay - Acute Lymphocytic Leukemia - Product Description 173
Chromosome 3 Companion Diagnostic Assay - Cervical Cancer - Product Status 174
Chromosome 3 Companion Diagnostic Assay - Cervical Cancer - Product Description 174
Chromosome 4 Companion Diagnostic Assay - Acute Lymphocytic Leukemia - Product Status 175
Chromosome 4 Companion Diagnostic Assay - Acute Lymphocytic Leukemia - Product Description 175
Chromosome 7 Companion Diagnostic Assay - Acute Lymphocytic Leukemia - Product Status 176
Chromosome 7 Companion Diagnostic Assay - Acute Lymphocytic Leukemia - Product Description 176
Chromosome 7 Companion Diagnostic Assay - Acute Myeloid Leukemia - Product Status 177
Chromosome 7 Companion Diagnostic Assay - Acute Myeloid Leukemia - Product Description 177
Chromosome 8 Companion Diagnostic Assay - Acute Myeloid Leukemia - Product Status 178
Chromosome 8 Companion Diagnostic Assay - Acute Myeloid Leukemia - Product Description 178
Chromosome X Companion Diagnostic Assay - Cervical Cancer - Product Status 179
Chromosome X Companion Diagnostic Assay - Cervical Cancer - Product Description 179
CKS1B Companion Diagnostic Assay - Breast Cancer - Product Status 180
CKS1B Companion Diagnostic Assay - Breast Cancer - Product Description 180
CKS1B Companion Diagnostic Assay - Multiple Myeloma - Product Status 181
CKS1B Companion Diagnostic Assay - Multiple Myeloma - Product Description 181
CLL FISH Probe Kit - Ibrutinib - Product Status 182
CLL FISH Probe Kit - Ibrutinib - Product Description 182
Companion Diagnostic Test - B-cell Lymphoma - Product Status 183
Companion Diagnostic Test - B-cell Lymphoma - Product Description 183
Companion Diagnostic Test - Cancer - Product Status 184
Companion Diagnostic Test - Cancer - Product Description 184
COT Companion Diagnostic Assay - Melanoma - Product Status 185
COT Companion Diagnostic Assay - Melanoma - Product Description 185
CRAF Companion Diagnostic Assay - Melanoma - Product Status 186
CRAF Companion Diagnostic Assay - Melanoma - Product Description 186
CRLF2 Companion Diagnostic Assay - Acute Lymphocytic Leukemia - Product Status 187
CRLF2 Companion Diagnostic Assay - Acute Lymphocytic Leukemia - Product Description 187
D13S319/Chromosome 12 Companion Diagnostic Assay - Chronic Lymphocytic Leukemia - Product Status 188
D13S319/Chromosome 12 Companion Diagnostic Assay - Chronic Lymphocytic Leukemia - Product Description 188
D5S23 Companion Diagnostic Assay - Cervical Cancer - Product Status 189
D5S23 Companion Diagnostic Assay - Cervical Cancer - Product Description 189
D5S23 Companion Diagnostic Assay - Multiple Myeloma - Product Status 190
D5S23 Companion Diagnostic Assay - Multiple Myeloma - Product Description 190
D5S721 Companion Diagnostic Assay - Acute Myeloid Leukemia - Product Status 191
D5S721 Companion Diagnostic Assay - Acute Myeloid Leukemia - Product Description 191
D5S721 Companion Diagnostic Assay - Cervical Cancer - Product Status 192
D5S721 Companion Diagnostic Assay - Cervical Cancer - Product Description 192
D7S486 Companion Diagnostic Assay - Acute Myeloid Leukemia - Product Status 193
D7S486 Companion Diagnostic Assay - Acute Myeloid Leukemia - Product Description 193
D7S486 Companion Diagnostic Assay - Myelodysplastic Syndrome - Product Status 194
D7S486 Companion Diagnostic Assay - Myelodysplastic Syndrome - Product Description 194
D7S552 Companion Diagnostic Assay - Acute Myeloid Leukemia - Product Status 195
D7S552 Companion Diagnostic Assay - Acute Myeloid Leukemia - Product Description 195
DCC Companion Diagnostic Assay - Colorectal Cancer - Product Status 196
DCC Companion Diagnostic Assay - Colorectal Cancer - Product Description 196
DDR2 Companion Diagnostic Assay - Lung Cancer - Product Status 197
DDR2 Companion Diagnostic Assay - Lung Cancer - Product Description 197
DEK/NUP214 Companion Diagnostic Assay - Acute Myeloid Leukemia - Product Status 198
DEK/NUP214 Companion Diagnostic Assay - Acute Myeloid Leukemia - Product Description 198
del(13q) Companion Diagnostic Assay - Myelodysplastic Syndrome - Product Status 199
del(13q) Companion Diagnostic Assay - Myelodysplastic Syndrome - Product Description 199
del(17p) Companion Diagnostic Assay - Chronic Lymphocytic Leukemia - Product Status 200
del(17p) Companion Diagnostic Assay - Chronic Lymphocytic Leukemia - Product Description 200
del(17p) Companion Diagnostic Assay - Multiple Myeloma - Product Status 201
del(17p) Companion Diagnostic Assay - Multiple Myeloma - Product Description 201
del(5q) Companion Diagnostic Assay - Myelodysplastic Syndrome - Product Status 202
del(5q) Companion Diagnostic Assay - Myelodysplastic Syndrome - Product Description 202
del(7q) Companion Diagnostic Assay - Myelodysplastic Syndrome - Product Status 203
del(7q) Companion Diagnostic Assay - Myelodysplastic Syndrome - Product Description 203
del(9q) Companion Diagnostic Assay - Myelodysplastic Syndrome - Product Status 204
del(9q) Companion Diagnostic Assay - Myelodysplastic Syndrome - Product Description 204
Diagnostic Assay - MTb Drug Resistance - Product Status 205
Diagnostic Assay - MTb Drug Resistance - Product Description 205
DOT1L Companion Diagnostic Test - Product Status 206
DOT1L Companion Diagnostic Test - Product Description 206
DPP4 Based Companion Diagnostic Assay - Asthma - Product Status 207
DPP4 Based Companion Diagnostic Assay - Asthma - Product Description 207
E2A/PDX1 Companion Diagnostic Assay - Acute Lymphocytic Leukemia - Product Status 208
E2A/PDX1 Companion Diagnostic Assay - Acute Lymphocytic Leukemia - Product Description 208
EGFR Companion Diagnostic Assay - Biliary Cancer - Product Status 209
EGFR Companion Diagnostic Assay - Biliary Cancer - Product Description 209
EGFR Companion Diagnostic Assay - Brain Cancer - Product Status 210
EGFR Companion Diagnostic Assay - Brain Cancer - Product Description 210
EGFR Companion Diagnostic Assay - Glioblastoma - Product Status 211
EGFR Companion Diagnostic Assay - Glioblastoma - Product Description 211
EGFR Companion Diagnostic Assay - Lung Cancer - Product Status 212
EGFR Companion Diagnostic Assay - Lung Cancer - Product Description 212
EGFRvIII Companion Diagnostic Assay - Glioblastoma - Product Status 213
EGFRvIII Companion Diagnostic Assay - Glioblastoma - Product Description 213
EGFRvIII Companion Diagnostic Assay - Lung Cancer - Product Status 214
EGFRvIII Companion Diagnostic Assay - Lung Cancer - Product Description 214
EGR1 Companion Diagnostic Assay - Acute Myeloid Leukemia - Product Status 215
EGR1 Companion Diagnostic Assay - Acute Myeloid Leukemia - Product Description 215
EGR1/D5S23 Companion Diagnostic Assay - Myelodysplastic Syndrome - Product Status 216
EGR1/D5S23 Companion Diagnostic Assay - Myelodysplastic Syndrome - Product Description 216
EML4 Companion Diagnostic Assay - Lung Cancer - Product Status 217
EML4 Companion Diagnostic Assay - Lung Cancer - Product Description 217
ERBB3 Companion Diagnostic Assay - Bladder Cancer - Product Status 218
ERBB3 Companion Diagnostic Assay - Bladder Cancer - Product Description 218
ERG Companion Diagnostic Assay - Prostate Cancer - Product Status 219
ERG Companion Diagnostic Assay - Prostate Cancer - Product Description 219
ETV Companion Diagnostic Assay - Sarcoma - Product Status 220
ETV Companion Diagnostic Assay - Sarcoma - Product Description 220
ETV1 Companion Diagnostic Assay - Prostate Cancer - Product Status 221
ETV1 Companion Diagnostic Assay - Prostate Cancer - Product Description 221
ETV6/RUNX1 Companion Diagnostic Assay - Acute Lymphocytic Leukemia - Product Status 222
ETV6/RUNX1 Companion Diagnostic Assay - Acute Lymphocytic Leukemia - Product Description 222
FGFR1 Companion Diagnostic Assay - Breast Cancer - Product Status 223
FGFR1 Companion Diagnostic Assay - Breast Cancer - Product Description 223
FGFR1 Companion Diagnostic Assay - Lung Cancer - Product Status 224
FGFR1 Companion Diagnostic Assay - Lung Cancer - Product Description 224
FGFR1 Companion Diagnostic Assay - Prostate Cancer - Product Status 225
FGFR1 Companion Diagnostic Assay - Prostate Cancer - Product Description 225
FGFR2 Companion Diagnostic Assay - Breast Cancer - Product Status 226
FGFR2 Companion Diagnostic Assay - Breast Cancer - Product Description 226
FGFR2 Companion Diagnostic Assay - Colorectal Cancer - Product Status 227
FGFR2 Companion Diagnostic Assay - Colorectal Cancer - Product Description 227
FGFR2 Companion Diagnostic Assay - Gastric Cancer - Product Status 228
FGFR2 Companion Diagnostic Assay - Gastric Cancer - Product Description 228
FGFR2 Companion Diagnostic Assay - Lung Cancer - Product Status 229
FGFR2 Companion Diagnostic Assay - Lung Cancer - Product Description 229
FGFR3 Companion Diagnostic Assay - Bladder Cancer - Product Status 230
FGFR3 Companion Diagnostic Assay - Bladder Cancer - Product Description 230
FGFR3-TACC3 Companion Diagnostic Assay - Bladder Cancer - Product Status 231
FGFR3-TACC3 Companion Diagnostic Assay - Bladder Cancer - Product Description 231
FGFR3-TACC3 Companion Diagnostic Assay - Lung Cancer - Product Status 232
FGFR3-TACC3 Companion Diagnostic Assay - Lung Cancer - Product Description 232
GNA11 Companion Diagnostic Assay - Melanoma - Product Status 233
GNA11 Companion Diagnostic Assay - Melanoma - Product Description 233
GNAQ Companion Diagnostic Assay - Melanoma - Product Status 234
GNAQ Companion Diagnostic Assay - Melanoma - Product Description 234
H3F3A Companion Diagnostic Assay - Glioblastoma - Product Status 235
H3F3A Companion Diagnostic Assay - Glioblastoma - Product Description 235
HER2 Companion Diagnostic Assay - Bladder Cancer - Product Status 236
HER2 Companion Diagnostic Assay - Bladder Cancer - Product Description 236
HER2 Companion Diagnostic Assay - Breast Cancer - Product Status 237
HER2 Companion Diagnostic Assay - Breast Cancer - Product Description 237
HER2 Companion Diagnostic Assay - Gastric Cancer - Product Status 238
HER2 Companion Diagnostic Assay - Gastric Cancer - Product Description 238
HER2 Companion Diagnostic Assay - Lung Cancer - Product Status 239
HER2 Companion Diagnostic Assay - Lung Cancer - Product Description 239
HER3 Companion Diagnostic Assay - Lung Cancer - Product Status 240
HER3 Companion Diagnostic Assay - Lung Cancer - Product Description 240
Heregulin Companion Diagnostic Assay - Lung Cancer - Product Status 241
Heregulin Companion Diagnostic Assay - Lung Cancer - Product Description 241
HIF-1alpha Companion Diagnostic Assay - Renal Cancer - Product Status 242
HIF-1alpha Companion Diagnostic Assay - Renal Cancer - Product Description 242
HOX11L2/TLX3 Companion Diagnostic Assay - Acute Lymphocytic Leukemia - Product Status 243
HOX11L2/TLX3 Companion Diagnostic Assay - Acute Lymphocytic Leukemia - Product Description 243
Hyperdiploidy Companion Diagnostic Assay - Multiple Myeloma - Product Status 244
Hyperdiploidy Companion Diagnostic Assay - Multiple Myeloma - Product Description 244
i(17q) Companion Diagnostic Assay - Myelodysplastic Syndrome - Product Status 245
i(17q) Companion Diagnostic Assay - Myelodysplastic Syndrome - Product Description 245
IDH1 Companion Diagnostic Assay - Biliary Cancer - Product Status 246
IDH1 Companion Diagnostic Assay - Biliary Cancer - Product Description 246
IDH1 Companion Diagnostic Assay - Glioblastoma - Product Status 247
IDH1 Companion Diagnostic Assay - Glioblastoma - Product Description 247
IDH1 Companion Diagnostic Assay - Leukemia - Product Status 248
IDH1 Companion Diagnostic Assay - Leukemia - Product Description 248
IDH1 Companion Diagnostic Assay - Sarcoma - Product Status 249
IDH1 Companion Diagnostic Assay - Sarcoma - Product Description 249
IDH2 Companion Diagnostic Assay - Glioblastoma - Product Status 250
IDH2 Companion Diagnostic Assay - Glioblastoma - Product Description 250
IDH2 Companion Diagnostic Assay - Sarcoma - Product Status 251
IDH2 Companion Diagnostic Assay - Sarcoma - Product Description 251
idic(Xq) Companion Diagnostic Assay - Myelodysplastic Syndrome - Product Status 252
idic(Xq) Companion Diagnostic Assay - Myelodysplastic Syndrome - Product Description 252
IGF1R Companion Diagnostic Assay - Breast Cancer - Product Status 253
IGF1R Companion Diagnostic Assay - Breast Cancer - Product Description 253
IGF1R Companion Diagnostic Assay - Lung Cancer - Product Status 254
IGF1R Companion Diagnostic Assay - Lung Cancer - Product Description 254
IGF1R Companion Diagnostic Assay - Melanoma - Product Status 255
IGF1R Companion Diagnostic Assay - Melanoma - Product Description 255
IGF1R Companion Diagnostic Assay - Prostate Cancer - Product Status 256
IGF1R Companion Diagnostic Assay - Prostate Cancer - Product Description 256
IGFR1 Companion Diagnostic Assay - Solid Tumor - Product Status 257
IGFR1 Companion Diagnostic Assay - Solid Tumor - Product Description 257
IGH/CCND1 t(11;14) Companion Diagnostic Assay - Chronic Lymphocytic Leukemia - Product Status 258
IGH/CCND1 t(11;14) Companion Diagnostic Assay - Chronic Lymphocytic Leukemia - Product Description 258
IGH/CCND1 t(11;14) Companion Diagnostic Assay - Multiple Myeloma - Product Status 259
IGH/CCND1 t(11;14) Companion Diagnostic Assay - Multiple Myeloma - Product Description 259
IGH/CCND3 t(6;14) Companion Diagnostic Assay - Multiple Myeloma - Product Status 260
IGH/CCND3 t(6;14) Companion Diagnostic Assay - Multiple Myeloma - Product Description 260
IGH/FGFR3 t(4;14) Companion Diagnostic Assay - Multiple Myeloma - Product Status 261
IGH/FGFR3 t(4;14) Companion Diagnostic Assay - Multiple Myeloma - Product Description 261
IGH/MAF t(14;16) Companion Diagnostic Assay - Multiple Myeloma - Product Status 262
IGH/MAF t(14;16) Companion Diagnostic Assay - Multiple Myeloma - Product Description 262
IGH/MAFB t(14;20) Companion Diagnostic Assay - Multiple Myeloma - Product Status 263
IGH/MAFB t(14;20) Companion Diagnostic Assay - Multiple Myeloma - Product Description 263
IGH/MALT t(14;18) Companion Diagnostic Assay - Chronic Lymphocytic Leukemia - Product Status 264
IGH/MALT t(14;18) Companion Diagnostic Assay - Chronic Lymphocytic Leukemia - Product Description 264
IGH/MALT t(14;18) Companion Diagnostic Assay - Lymphoma - Product Status 265
IGH/MALT t(14;18) Companion Diagnostic Assay - Lymphoma - Product Description 265
IGH/MYC t(8;14) Companion Diagnostic Assay - Lymphoma - Product Status 266
IGH/MYC t(8;14) Companion Diagnostic Assay - Lymphoma - Product Description 266
IKZF1 Companion Diagnostic Assay - Acute Lymphocytic Leukemia - Product Status 267
IKZF1 Companion Diagnostic Assay - Acute Lymphocytic Leukemia - Product Description 267
inv(16) Companion Diagnostic Assay - Myelodysplastic Syndrome - Product Status 268
inv(16) Companion Diagnostic Assay - Myelodysplastic Syndrome - Product Description 268
inv(17q) Companion Diagnostic Assay - Myelodysplastic Syndrome - Product Status 269
inv(17q) Companion Diagnostic Assay - Myelodysplastic Syndrome - Product Description 269
inv(3) Companion Diagnostic Assay - Myelodysplastic Syndrome - Product Status 270
inv(3) Companion Diagnostic Assay - Myelodysplastic Syndrome - Product Description 270
JAK2 Companion Diagnostic Assay - Breast Cancer - Product Status 271
JAK2 Companion Diagnostic Assay - Breast Cancer - Product Description 271
KEAP1 Companion Diagnostic Assay - Lung Cancer - Product Status 272
KEAP1 Companion Diagnostic Assay - Lung Cancer - Product Description 272
KIF5B Companion Diagnostic Assay - Lung Cancer - Product Status 273
KIF5B Companion Diagnostic Assay - Lung C

List of Figures
Abbott Diagnostics Pipeline Products by Equipment Type 29
Abbott Diagnostics Pipeline Products by Development Stage 41
Abbott Diagnostics Ongoing Clinical Trials by Trial Status 57

★海外企業調査レポート[Abbott Diagnostics:企業の製品パイプライン分析2018]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • HDR, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' HDR, Inc. Mergers and Acquisiti …
  • Toyo Kanetsu K.K.:企業の戦略・SWOT・財務分析
    SummaryToyo Kanetsu K.K. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findi …
  • Eurasia Drilling Company:企業のM&A・提携動向(石油・ガス分野)
    Summary Eurasia Drilling Company (EDC) is an oil and gas company that offers exploitation services. The company provides drilling and mineral exploration services. It offers onshore drilling, rig fleet services, work-over services, side tracking services and offshore drilling services. EDC’s onshore …
  • InterSystems Corporation:企業のM&A・提携動向(医療機器分野)
    Summary InterSystems Corporation (InterSystems) is a provider of IT solutions offering advanced data management, connectivity, and analytics technologies. It offers information engines that power important applications in the healthcare, financial services, telecommunication, governments and other s …
  • AFC Energy plc (AFC):企業の財務・戦略的SWOT分析
    Summary AFC Energy Plc (AFC Energy) is a developer of alkaline fuel cells. The company's projects include Power-Up and Alkammonia. Its power generation technology is used in the industrial markets and produces heat, water, and electricity. AFC Energy provides its electricity for industrial applicati …
  • Asarina Pharma AB-製薬・医療分野:企業M&A・提携分析
    Summary Asarina Pharma AB (Asarina Pharma), formerly Umecrine Mood AB, a subsidiary of Umecrine AB is a drug development company that concentrates on the discovery, development and commercialization of novel treatments for women suffering from premenstrual dysphoric disorder and other menstrual cycl …
  • Bodal Chemicals Ltd. (BODALCHEM):企業財務及び戦略的SWOT分析
    Summary Bodal Chemicals Ltd. (Bodal) is a chemical company that manufactures dyes, intermediates and sulphur and bulk chemical. The company offer products such as dyes intermediates, acid and direct dyes, and reactive dyes. Its dye intermediates include vinyl sulphone ester, vinyl sulphone, paracres …
  • Chembio Diagnostic Inc (CEMI):医療機器:M&Aディール及び事業提携情報
    Summary Chembio Diagnostic Inc (Chembio) develops, manufactures, markets and licenses point-of-care diagnostic (POCs) tests for the detection of infectious diseases. The company offers products to prevent the spread of infectious diseases with solutions like Dual Path Platform (DPP). Its DPP technol …
  • KCOM Group PLC (KCOM):企業財務及び戦略的SWOT分析
    Summary KCOM Group PLC (KCOM) is a technology and communications company that provides telecommunication and information technology services. The company also offers services in operating, managing and supplying telecommunication systems and related services. Its key services include voice services, …
  • Orbis S.A.:戦略・SWOT・企業財務分析
    Orbis S.A. - Strategy, SWOT and Corporate Finance Report Summary Orbis S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Nyherji hf. (NYHR):企業財務及び戦略的SWOT分析
    Summary Nyherji hf. (Nyherji) is a technology company that offers hardware and software solutions, audio visual solutions and services. The company offers systems integration, applications development, facilities management and expert business process consultancy. It offers quality management and sa …
  • Regado Biosciences, Inc. (RGDO):(医療機器分野)企業M&A及び提携動向
    Summary Regado Biosciences, Inc. (Regado) is a pharmaceutical company. The company discovers and develops actively controllable antithrombotic drug systems for acute and sub acute cardiovascular indications. Its products include REG1, REG2 and REG3. The company’s lead product candidate, REG1, is an …
  • SP Plus Corporation (formerly Standard Parking Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' SP Plus Corporation (formerly S …
  • GE Oil & Gas:企業のM&A・提携動向(石油・ガス分野)
    Summary GE Oil & Gas (GEOG), a business unit of the General Electric Company, offers advanced technological equipment and services for all segments of the oil and gas industry, from exploration and production to downstream. The company designs and manufactures surface and subsea drilling and product …
  • Magellan Midstream Partners LP (MMP):石油・ガス:M&Aディール及び事業提携情報
    Summary Magellan Midstream Partners LP (Magellan Midstream) is a midstream energy company. It transports, stores, and distributes refined petroleum products and crude oil. The company handles various petroleum products such as gasoline, diesel fuel, and crude oil. Magellan Midstream owns and operate …
  • North American Energy Resources, Inc. (formerly Mar Ked Mineral Exploration, Inc.):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' North American Energy Resources …
  • NuMobile, Inc. (formerly Phoenix Interests, Inc.):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' NuMobile, Inc. (formerly Phoeni …
  • PricewaterhouseCoopers LLP (UK):企業概要及び戦略的SWOT分析
    PricewaterhouseCoopers LLP (UK) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Steppe Cement Ltd:企業の戦略・SWOT・財務分析
    SummarySteppe Cement Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findi …
  • Strategic Oil and Gas, Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Strategic Oil and Gas, Ltd. Mer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆